Latest news from ATCC
ATCC Secures NIAID Contract to Strengthen U.S. Preparedness Against Emerging Infectious Diseases
ATCC expands its partnership with NIAID, advancing U.S. readiness against emerging infectious diseases through enhanced testing and assay development.
ATCC Expands Role in Supporting the NIST's Monoclonal Antibody Reference Materials
ATCC expands its collaboration with NIST to deliver trusted monoclonal antibody reference materials that strengthen reproducibility and accelerate therapeutic innovation.
ATCC hosts the NSCEB's “Biotech Across America” roadshow
ATCC and NSCEB host discussions on the critical role of authenticated biomaterials in a secure and resilient bioeconomy.
ATCC Receives Contract to Advance Industrial Biomanufacturing and Produce Synthetic Aviation Fuel Precursors
ATCC was granted a contract with Capra Biosciences to work on the DARPA Switch program to help identify novel metabolic feedstock utilization genes for use in new biomanufacturing technology.